WAP
SURF

Wealthcare Advisory Partners’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Wealthcare Advisory Partners’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$4K – 2007
2021
Q1 		$4K Buy
+500
New +$5K ﹤0.01% 1745

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wealthcare Advisory Partners's SURF Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2021, closing a stake of 500 shares — an estimated $4K sold.

Wealthcare Advisory Partners first reported a position in SURF in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 96 funds tracked by Wall St. Rank hold SURF as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 500 Surface Oncology, Inc. Common Stock shares in Q2 2021, an estimated $4K.
  • Wealthcare Advisory Partners first reported a position in Surface Oncology, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Wealthcare Advisory Partners's Surface Oncology, Inc. Common Stock position peaked at $4K in Q1 2021.
  • 96 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.